2022 China Ophthalmic Regulatory Science and Standardization Conference Successfully Held: Focusing on Eye Health Industry and Envisioning Future Development

On November 11, the Annual Meeting of the NMPA Key Laboratory for Research and Evaluation of Ophthalmic Drugs and Medical Devices, together with the 2022 China Conference on Regulatory Science and Standardization in Ophthalmology, was successfully held in Longwan, Wenzhou. The event was hosted by the Zhejiang Association for Science and Technology and the Wenzhou Municipal People’s Government, and organized by China Eye Valley in collaboration with the Eye Hospital of Wenzhou Medical University and other relevant institutions.

As a key segment of the 2022 International Summit on Technological Innovation and Industrial Development in Eye Health and the Global Challenge for Innovation and Entrepreneurship in Optometry at China Eye Valley, the 2022 China Conference on Ophthalmic Regulatory Science and Standardization brought together numerous industry leaders and covered six major sectors: government, industry, academia, research, healthcare, and investment. These distinguished experts delivered insightful keynote speeches, shared perspectives on ophthalmic regulatory science, and discussed future trends in the eye health industry, offering attendees an intellectual feast that enriched their professional understanding. The conference was moderated by Dr. Liang Yuanbo, Deputy Director of the Eye Hospital of Wenzhou Medical University, and Dr. Sun Xin, Director of the Chinese Center for Evidence-Based Medicine at West China Hospital, Sichuan University.

Left: Sun Xin, Director of the Chinese Cochrane Center at West China Hospital, Sichuan University; Right: Liang Yuanbo, Vice President of the Eye Hospital of Wenzhou Medical University

At the opening of the conference, Qu Jia, Director of the Department of Ophthalmology and Optometry at Wenzhou Medical University and Chairman of China Eye Valley, delivered the opening remarks: Guided by clinical needs, implementing scientific and standardized administrative supervision, and establishing universal and detailed industry standards have become major practical issues that need to be addressed for the sustainable and healthy development of the optometry and ophthalmology industry.

Qu Jia, Director of the Department of Optometry and Ophthalmology at Wenzhou Medical University and Chairman of China Eye Valley, Delivers Opening Remarks

Mao Zhenbin, a First-Level Inspector at the former China Food and Drug Administration, stated in his address that conducting research on ophthalmic standards science and standardization is of great significance for regulating the development of the ophthalmic pharmaceutical and medical device industry, fostering a fair and orderly business environment, and encouraging technological innovation and product advancement in the eye health sector.

Address by Mao Zhenbin, First-Level Inspector of the Former China Food and Drug Administration

At the conference, industry leaders delivered insightful keynote speeches.

Sun Xin, Director of the Chinese Evidence-Based Medicine Center at West China Hospital, Sichuan University

“Evolution of Regulatory Science Research Methods from the Perspective of Real-World Studies”

Hou Yan, Researcher and Doctoral Supervisor, Department of Biostatistics, Peking University

“Development of China’s Regulatory Science in Statistics from the Perspectives of ICH E17 and E9(R1)”

Zhang Li, Deputy Director of Zhejiang Institute for Medical Device Testing

“Overview of Standard Testing for Common Ophthalmic Instruments”

Wang Chunren, Researcher at the National Institutes for Food and Drug Control (NIFDC), Former Director of the Biomaterials Division, Institute for Medical Device Testing

"Technical Requirements and Standards for Ophthalmic Optical Medical Device Registration-Related Products"

Liu Xiaogang, Member of the Party Leadership Group and Deputy Director of the Hainan Provincial Medical Products Administration

“Introduction to the Pilot Program for Special Drugs and Medical Devices and Real-World Research in Hainan Province”

Yao Chen, Deputy Director of the Clinical Research Institute at Peking University

“Exploration of Real-World Data Collection Models”

Chang Limei, Head of Medical Device Review, Hainan Provincial Center for Drug and Medical Device Evaluation Services

"Clinical Evaluation Research of Real-World Data under Scientific Supervision"